{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:53:26Z","timestamp":1776214406272,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Resarch Foundation of Korea","award":["2022R1A2C2091254"],"award-info":[{"award-number":["2022R1A2C2091254"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00415-025-13559-2","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T08:20:00Z","timestamp":1765182000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Plasma neurofilament light chain as a predictor of multiple system atrophy in idiopathic REM sleep behavior disorder"],"prefix":"10.1007","volume":"273","author":[{"given":"Bora","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seoyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Hyeon","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Ah","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Hwan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Young","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8219-9663","authenticated-orcid":false,"given":"Han-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"issue":"6","key":"13559_CR1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/jamaneurol.2014.4563","volume":"72","author":"MJ Howell","year":"2015","unstructured":"Howell MJ, Schenck CH (2015) Rapid eye movement sleep behavior disorder and neurodegenerative disease. JAMA Neurol 72(6):707\u2013712. https:\/\/doi.org\/10.1001\/jamaneurol.2014.4563","journal-title":"JAMA Neurol"},{"issue":"3","key":"13559_CR2","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/brain\/awz030","volume":"142","author":"RB Postuma","year":"2019","unstructured":"Postuma RB, Iranzo A, Hu M, H\u00f6gl B, Boeve BF, Manni R, Oertel WH, Arnulf I, Ferini-Strambi L, Puligheddu M, Antelmi E, Cochen De Cock V, Arnaldi D, Mollenhauer B, Videnovic A, Sonka K, Jung KY, Kunz D, Dauvilliers Y, Provini F, Lewis SJ, Buskova J, Pavlova M, Heidbreder A, Montplaisir JY, Santamaria J, Barber TR, Stefani A, St Louis EK, Terzaghi M, Janzen A, Leu-Semenescu S, Plazzi G, Nobili F, Sixel-Doering F, Dusek P, Bes F, Cortelli P, Ehgoetz Martens K, Gagnon JF, Gaig C, Zucconi M, Trenkwalder C, Gan-Or Z, Lo C, Rolinski M, Mahlknecht P, Holzknecht E, Boeve AR, Teigen LN, Toscano G, Mayer G, Morbelli S, Dawson B, Pelletier A (2019) Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain 142(3):744\u2013759. https:\/\/doi.org\/10.1093\/brain\/awz030","journal-title":"Brain"},{"issue":"24","key":"13559_CR3","doi-asserted-by":"publisher","first-page":"e2413","DOI":"10.1212\/WNL.0000000000200326","volume":"98","author":"EJ Yoon","year":"2022","unstructured":"Yoon EJ, Lee JY, Kim H, Yoo D, Shin JH, Nam H, Jeon B, Kim YK (2022) Brain metabolism related to mild cognitive impairment and phenoconversion in patients with isolated REM sleep behavior disorder. Neurology 98(24):e2413\u2013e2424. https:\/\/doi.org\/10.1212\/WNL.0000000000200326","journal-title":"Neurology"},{"issue":"1\u20132","key":"13559_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","volume":"233","author":"A Petzold","year":"2005","unstructured":"Petzold A (2005) Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 233(1\u20132):183\u2013198. https:\/\/doi.org\/10.1016\/j.jns.2005.03.015","journal-title":"J Neurol Sci"},{"issue":"2","key":"13559_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.neuron.2016.07.007","volume":"91","author":"M Bacioglu","year":"2016","unstructured":"Bacioglu M, Maia LF, Preische O, Schelle J, Apel A, Kaeser SA, Schweighauser M, Eninger T, Lambert M, Pilotto A, Shimshek DR, Neumann U, Kahle PJ, Staufenbiel M, Neumann M, Maetzler W, Kuhle J, Jucker M (2016) Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases. Neuron 91(2):494\u2013496. https:\/\/doi.org\/10.1016\/j.neuron.2016.07.007","journal-title":"Neuron"},{"issue":"13","key":"13559_CR6","doi-asserted-by":"publisher","first-page":"e1479","DOI":"10.1212\/WNL.0000000000007179","volume":"92","author":"TM Marques","year":"2019","unstructured":"Marques TM, van Rumund A, Oeckl P, Kuiperij HB, Esselink RAJ, Bloem BR, Otto M, Verbeek MM (2019) Serum NFL discriminates Parkinson disease from atypical parkinsonisms. Neurology 92(13):e1479\u2013e1486. https:\/\/doi.org\/10.1212\/WNL.0000000000007179","journal-title":"Neurology"},{"issue":"12","key":"13559_CR7","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1002\/mds.28738","volume":"36","author":"I Schulz","year":"2021","unstructured":"Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S, Otte B, Bartl M, Hutten SJ, Trenkwalder C, Mollenhauer B (2021) Systematic assessment of 10 biomarker candidates focusing on \u03b1-synuclein-related disorders. Mov Disord 36(12):2874\u20132887. https:\/\/doi.org\/10.1002\/mds.28738","journal-title":"Mov Disord"},{"issue":"11","key":"13559_CR8","doi-asserted-by":"publisher","first-page":"e1104","DOI":"10.1212\/WNL.0000000000008088","volume":"93","author":"CH Lin","year":"2019","unstructured":"Lin CH, Li CH, Yang KC, Lin FJ, Wu CC, Chieh JJ, Chiu MJ (2019) Blood NfL: a biomarker for disease severity and progression in Parkinson disease. Neurology 93(11):e1104\u2013e1111. https:\/\/doi.org\/10.1212\/WNL.0000000000008088","journal-title":"Neurology"},{"issue":"12","key":"13559_CR9","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/mds.28779","volume":"36","author":"WW Aamodt","year":"2021","unstructured":"Aamodt WW, Waligorska T, Shen J, Tropea TF, Siderowf A, Weintraub D, Grossman M, Irwin D, Wolk DA, Xie SX, Trojanowski JQ, Shaw LM, Chen-Plotkin AS (2021) Neurofilament light chain as a biomarker for cognitive decline in Parkinson disease. Mov Disord 36(12):2945\u20132950. https:\/\/doi.org\/10.1002\/mds.28779","journal-title":"Mov Disord"},{"issue":"2","key":"13559_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/mds.28847","volume":"37","author":"L Zhang","year":"2022","unstructured":"Zhang L, Cao B, Hou Y, Gu X, Wei Q, Ou R, Zhao B, Luo C, Shang H (2022) Neurofilament light chain predicts disease severity and progression in multiple system atrophy. Mov Disord 37(2):421\u2013426. https:\/\/doi.org\/10.1002\/mds.28847","journal-title":"Mov Disord"},{"issue":"1","key":"13559_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00768-1","volume":"10","author":"CC Pedersen","year":"2024","unstructured":"Pedersen CC, Ushakova A, Alves G, Tysnes OB, Blennow K, Zetterberg H, Maple-Gr\u00f8dem J, Lange J (2024) Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson\u2019s Disease. NPJ Parkinsons Dis 10(1):162. https:\/\/doi.org\/10.1038\/s41531-024-00768-1","journal-title":"NPJ Parkinsons Dis"},{"issue":"4","key":"13559_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3233\/JPD-223519","volume":"13","author":"X Zhang","year":"2023","unstructured":"Zhang X, Ma L, Liang D, Song B, Chen J, Huang Y, Xu L, Zhao P, Wu W, Zhang N, Xue R (2023) Neurofilament light protein predicts disease progression in idiopathic REM sleep behavior disorder. J Parkinsons Dis 13(4):485\u2013499. https:\/\/doi.org\/10.3233\/JPD-223519","journal-title":"J Parkinsons Dis"},{"issue":"7","key":"13559_CR13","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/mds.28026","volume":"35","author":"C Wilke","year":"2020","unstructured":"Wilke C, Dos Santos MCT, Schulte C, Deuschle C, Scheller D, Verbelen M, Brockmann K, von Thaler AK, S\u00fcnkel U, Roeben B, Bujac S, Metzger FG, Maetzler W, da Costa AN, Synofzik M, Berg D (2020) Intraindividual neurofilament dynamics in serum mark the conversion to sporadic Parkinson\u2019s disease. Mov Disord 35(7):1233\u20131238. https:\/\/doi.org\/10.1002\/mds.28026","journal-title":"Mov Disord"},{"issue":"9","key":"13559_CR14","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1007\/s00415-023-11785-0","volume":"270","author":"DG Park","year":"2023","unstructured":"Park DG, Kim JY, Kim MS, Kim MH, An YS, Chang J, Yoon JH (2023) Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder. J Neurol 270(9):4393\u20134402. https:\/\/doi.org\/10.1007\/s00415-023-11785-0","journal-title":"J Neurol"},{"issue":"1","key":"13559_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03120-1","volume":"21","author":"J Lin","year":"2023","unstructured":"Lin J, Ou R, Li C, Hou Y, Zhang L, Wei Q, Pang D, Liu K, Jiang Q, Yang T, Xiao Y, Zhao B, Chen X, Song W, Yang J, Wu Y, Shang H (2023) Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson\u2019s disease: a prospective cohort study. BMC Med 21(1):420. https:\/\/doi.org\/10.1186\/s12916-023-03120-1","journal-title":"BMC Med"},{"issue":"2","key":"13559_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/jnc.15780","volume":"165","author":"X Teng","year":"2023","unstructured":"Teng X, Mao S, Wu H, Shao Q, Zu J, Zhang W, Zhou S, Zhang T, Zhu J, Cui G, Xu C (2023) The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson\u2019s disease. J Neurochem 165(2):268\u2013276. https:\/\/doi.org\/10.1111\/jnc.15780","journal-title":"J Neurochem"},{"issue":"1","key":"13559_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00481-5","volume":"9","author":"Y Guo","year":"2023","unstructured":"Guo Y, Shen XN, Huang SY, Chen SF, Wang HF, Zhang W, Zhang YR, Cheng W, Cui M, Dong Q, Yu JT (2023) Head-to-head comparison of 6 plasma biomarkers in early multiple system atrophy. NPJ Parkinsons Dis 9(1):40. https:\/\/doi.org\/10.1038\/s41531-023-00481-5","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"13559_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00447-7","volume":"9","author":"Y Tang","year":"2023","unstructured":"Tang Y, Han L, Li S, Hu T, Xu Z, Fan Y, Liang X, Yu H, Wu J, Wang J (2023) Plasma GFAP in Parkinson\u2019s disease with cognitive impairment and its potential to predict conversion to dementia. NPJ Parkinsons Dis 9(1):23. https:\/\/doi.org\/10.1038\/s41531-023-00447-7","journal-title":"NPJ Parkinsons Dis"},{"issue":"10","key":"13559_CR19","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.1007\/s00415-024-12647-z","volume":"271","author":"S Katzdobler","year":"2024","unstructured":"Katzdobler S, N\u00fcbling G, Klietz M, Fietzek UM, Palleis C, Bernhardt AM, Wegner F, Huber M, Rogozinski S, Schneider LS, Spruth EJ, Beyle A, Vogt IR, Brandt M, Hansen N, Glanz W, Brockmann K, Spottke A, Hoffmann DC, Peters O, Priller J, Wiltfang J, D\u00fczel E, Schneider A, Falkenburger B, Klockgether T, Gasser T, Nuscher B, Haass C, H\u00f6glinger G, Levin J (2024) GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA). J Neurol 271(10):6991\u20136999. https:\/\/doi.org\/10.1007\/s00415-024-12647-z","journal-title":"J Neurol"},{"issue":"1","key":"13559_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00172-z","volume":"7","author":"A van Rumund","year":"2021","unstructured":"van Rumund A, Pavelka L, Esselink RAJ, Geurtz BPM, Wevers RA, Mollenhauer B, Kr\u00fcger R, Bloem BR, Verbeek MM (2021) Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase. NPJ Parkinsons Dis 7(1):29. https:\/\/doi.org\/10.1038\/s41531-021-00172-z","journal-title":"NPJ Parkinsons Dis"},{"issue":"10","key":"13559_CR21","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s43587-023-00478-y","volume":"3","author":"JB Pereira","year":"2023","unstructured":"Pereira JB, Kumar A, Hall S, Palmqvist S, Stomrud E, Bali D, Parchi P, Mattsson-Carlgren N, Janelidze S, Hansson O (2023) DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease. Nat Aging 3(10):1201\u20131209. https:\/\/doi.org\/10.1038\/s43587-023-00478-y","journal-title":"Nat Aging"},{"issue":"5","key":"13559_CR22","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/chest.14-0970","volume":"146","author":"MJ Sateia","year":"2014","unstructured":"Sateia MJ (2014) International classification of sleep disorders-third edition: highlights and modifications. Chest 146(5):1387\u20131394. https:\/\/doi.org\/10.1378\/chest.14-0970","journal-title":"Chest"},{"issue":"12","key":"13559_CR23","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"6","key":"13559_CR24","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K, Palma JA, Meissner WG, Krismer F, Berg D, Cortelli P, Freeman R, Halliday G, H\u00f6glinger G, Lang A, Ling H, Litvan I, Low P, Miki Y, Panicker J, Pellecchia MT, Quinn N, Sakakibara R, Stamelou M, Tolosa E, Tsuji S, Warner T, Poewe W, Kaufmann H (2022) The Movement Disorder Society criteria for the diagnosis of multiple system atrophy. Mov Disord 37(6):1131\u20131148. https:\/\/doi.org\/10.1002\/mds.29005","journal-title":"Mov Disord"},{"issue":"1","key":"13559_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O\u2019Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89(1):88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058","journal-title":"Neurology"},{"issue":"12","key":"13559_CR26","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.5664\/jcsm.6840","volume":"13","author":"S You","year":"2017","unstructured":"You S, Moon HJ, Do SY, Wing YK, Sunwoo JS, Jung KY, Cho YW (2017) The REM sleep behavior disorder screening questionnaire: validation study of the Korean version (RBDQ-KR). J Clin Sleep Med 13(12):1429\u20131433. https:\/\/doi.org\/10.5664\/jcsm.6840","journal-title":"J Clin Sleep Med"},{"issue":"3","key":"13559_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.anl.2008.07.005","volume":"36","author":"JH Cho","year":"2009","unstructured":"Cho JH, Jeong YS, Lee YJ, Hong SC, Yoon JH, Kim JK (2009) The Korean version of the Sniffin\u2019 stick (KVSS) test and its validity in comparison with the cross-cultural smell identification test (CC-SIT). Auris Nasus Larynx 36(3):280\u2013286. https:\/\/doi.org\/10.1016\/j.anl.2008.07.005","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"13559_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.14802\/jmd.16057","volume":"10","author":"JY Kim","year":"2017","unstructured":"Kim JY, Song IU, Koh SB, Ahn TB, Kim SJ, Cheon SM, Cho JW, Kim YJ, Ma HI, Park MY, Baik JS, Lee PH, Chung SJ, Kim JM, Kim HJ, Sung YH, Kwon DY, Lee JH, Lee JY, Kim JS, Yun JY, Kim HJ, Hong JY, Kim MJ, Youn J, Kim JS, Oh ES, Yang HJ, Yoon WT, You S, Kwon KY, Park HE, Lee SY, Kim Y, Kim HT, Kim JS (2017) Validation of the Korean version of the scale for outcomes in Parkinson\u2019s disease-autonomic. J Mov Disord 10(1):29\u201334. https:\/\/doi.org\/10.14802\/jmd.16057","journal-title":"J Mov Disord"},{"issue":"12","key":"13559_CR29","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2015) MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 30(12):1600\u20131611. https:\/\/doi.org\/10.1002\/mds.26431","journal-title":"Mov Disord"},{"issue":"10","key":"13559_CR30","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","volume":"34","author":"S Heinzel","year":"2019","unstructured":"Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB, MDS Task Force on the Definition of Parkinson\u2019s Disease (2019) Update of the MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 34(10):1464\u20131470. https:\/\/doi.org\/10.1002\/mds.27802","journal-title":"Mov Disord"},{"issue":"3","key":"13559_CR31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.21053\/ceo.2020.00864","volume":"13","author":"JG Ha","year":"2020","unstructured":"Ha JG, Kim J, Nam JS, Park JJ, Cho HJ, Yoon JH, Kim CH (2020) Development of a Korean culture-friendly olfactory function test and optimization of a diagnostic cutoff value. Clin Exp Otorhinolaryngol 13(3):274\u2013284. https:\/\/doi.org\/10.21053\/ceo.2020.00864","journal-title":"Clin Exp Otorhinolaryngol"},{"issue":"21","key":"13559_CR32","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1212\/WNL.0b013e3181c34b47","volume":"73","author":"S Hoops","year":"2009","unstructured":"Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D (2009) Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73(21):1738\u20131745. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c34b47","journal-title":"Neurology"},{"issue":"10","key":"13559_CR33","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/mds.25122","volume":"27","author":"CG Goetz","year":"2012","unstructured":"Goetz CG, Stebbins GT, Tilley BC (2012) Calibration of unified Parkinson\u2019s disease rating scale scores to Movement Disorder Society-unified Parkinson\u2019s disease rating scale scores. Mov Disord 27(10):1239\u20131242. https:\/\/doi.org\/10.1002\/mds.25122","journal-title":"Mov Disord"},{"issue":"1","key":"13559_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10072-021-05746-6","volume":"43","author":"F Leys","year":"2022","unstructured":"Leys F, Wenning GK, Fanciulli A (2022) The role of cardiovascular autonomic failure in the differential diagnosis of \u03b1-synucleinopathies. Neurol Sci 43(1):187\u2013198","journal-title":"Neurol Sci"},{"issue":"1","key":"13559_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-024-02706-0","volume":"147","author":"J Rutledge","year":"2024","unstructured":"Rutledge J, Lehallier B, Zarifkar P, Losada PM, Shahid-Besanti M, Western D, Gorijala P, Ryman S, Yutsis M, Deutsch GK, Mormino E, Trelle A, Wagner AD, Kerchner GA, Tian L, Cruchaga C, Henderson VW, Montine TJ, Borghammer P, Wyss-Coray T, Poston KL (2024) Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson\u2019s disease. Acta Neuropathol 147(1):52. https:\/\/doi.org\/10.1007\/s00401-024-02706-0","journal-title":"Acta Neuropathol"},{"issue":"1","key":"13559_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56293-z","volume":"16","author":"K Bolsewig","year":"2025","unstructured":"Bolsewig K, Willemse EAJ, S\u00e1nchez-Juan P, R\u00e1bano A, Mart\u00ednez M, Doecke JD, Bellomo G, Vermunt L, Alcolea D, Halbgebauer S, t Veld S, Mattsson-Carlgren N, Veverova K, Fowler CJ, Boonkamp L, Koel-Simmelink M, Hussainali Z, Ruiters DN, Gaetani L, Toja A, Fortea J, Pijnenburg Y, Lemstra AW, van der Flier WM, Hort J, Otto M, Hansson O, Parnetti L, Masters CL, Lle\u00f3 A, Teunissen CE, Del Campo Mil\u00e1n M (2025) Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment. Nat Commun 16(1):1139. https:\/\/doi.org\/10.1038\/s41467-025-56293-z","journal-title":"Nat Commun"},{"issue":"1","key":"13559_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41531-021-00232-4","volume":"7","author":"C Quadalti","year":"2021","unstructured":"Quadalti C, Calandra-Buonaura G, Baiardi S, Mastrangelo A, Rossi M, Zenesini C, Giannini G, Candelise N, Sambati L, Polischi B, Plazzi G, Capellari S, Cortelli P, Parchi P (2021) Neurofilament light chain and \u03b1-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes. NPJ Parkinsons Dis 7(1):93. https:\/\/doi.org\/10.1038\/s41531-021-00232-4","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"13559_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.18632\/aging.101704","volume":"11","author":"KA Walker","year":"2018","unstructured":"Walker KA (2018) Inflammation and neurodegeneration: chronicity matters. Aging (Albany NY) 11(1):3\u20134. https:\/\/doi.org\/10.18632\/aging.101704","journal-title":"Aging (Albany NY)"},{"key":"13559_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119975","volume":"565","author":"Y Chen","year":"2025","unstructured":"Chen Y, Huang J, Li Y, Chen X, Ye Q (2025) Diagnostic value of six plasma biomarkers in progressive supranuclear palsy, multiple system atrophy, and Parkinson\u2019s disease. Clin Chim Acta 565:119975. https:\/\/doi.org\/10.1016\/j.cca.2024.119975","journal-title":"Clin Chim Acta"},{"key":"13559_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsaf163","author":"C Liguori","year":"2025","unstructured":"Liguori C, Fernandes M, Zatti C et al (2025) Plasma NfL, GFAP and pTau181 in patients with isolated REM sleep behaviour disorder. Sleep. https:\/\/doi.org\/10.1093\/sleep\/zsaf163. (Published online June 9, 2025)","journal-title":"Sleep"},{"key":"13559_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/mds.70016","author":"A Delva","year":"2025","unstructured":"Delva A, Zatti C, Pelletier A et al (2025) Plasma markers of astrocytic and axonal integrity in Idiopathic\/Isolated REM Sleep Behavior Disorder (iRBD) as predictors of dementia with Lewy bodies. Mov Disord. https:\/\/doi.org\/10.1002\/mds.70016","journal-title":"Mov Disord"},{"issue":"1","key":"13559_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00421-0","volume":"13","author":"E Appleton","year":"2024","unstructured":"Appleton E, Khosousi S, Ta M, Nalls M, Singleton AB, Sturchio A, Markaki I, Paslawski W, Iwaki H, Svenningsson P (2024) DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson\u2019s disease. Transl Neurodegener 13(1):31. https:\/\/doi.org\/10.1186\/s40035-024-00421-0","journal-title":"Transl Neurodegener"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13559-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13559-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13559-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:57:54Z","timestamp":1773665874000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13559-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["13559"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13559-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Each participant provided written, informed consent. The study was approved by the Ethics Committee of the Seoul National University Hospital, and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"13"}}